155 related articles for article (PubMed ID: 34659532)
1. DDIT4 overexpression associates with poor prognosis in lung adenocarcinoma.
Song L; Chen Z; Zhang M; Zhang M; Lu X; Li C; Miao L
J Cancer; 2021; 12(21):6422-6428. PubMed ID: 34659532
[No Abstract] [Full Text] [Related]
2. Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma.
Guo W; Huai Q; Zhang G; Guo L; Song P; Xue X; Tan F; Xue Q; Gao S; He J
Front Oncol; 2020; 10():598437. PubMed ID: 33569346
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic analysis of Rho GTPase-activating protein 11A in lung adenocarcinoma.
Chen S; Duan H; Xie Y; Li X; Zhao Y
Ann Transl Med; 2021 May; 9(10):872. PubMed ID: 34164506
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of SLC35F2 is a potential prognostic biomarker for lung adenocarcinoma.
Zheng Q; Li M; Qiu Y; Yang J; Cao Y
Heliyon; 2024 Jan; 10(1):e23828. PubMed ID: 38187235
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
Tian Q; Zhou Y; Zhu L; Gao H; Yang J
Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
[No Abstract] [Full Text] [Related]
6. Elevated expression of Twinfilin-1 is correlated with inferior prognosis of lung adenocarcinoma.
Kaishang Z; Xue P; Shaozhong Z; Yingying F; Yan Z; Chanjun S; Zhenzhen L; Xiangnan L
Life Sci; 2018 Dec; 215():159-169. PubMed ID: 30391462
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma.
Zhang JT; Lin YC; Xiao BF; Yu BT
Med Sci Monit; 2019 Jun; 25():4264-4272. PubMed ID: 31175804
[TBL] [Abstract][Full Text] [Related]
8. Molecular and Immune Characteristics for Lung Adenocarcinoma Patients With ERLIN2 Overexpression.
Liu Y; Xie P; Jiang D; Liu J; Zhang J; Bian T; Shi J
Front Immunol; 2020; 11():568440. PubMed ID: 33424830
[TBL] [Abstract][Full Text] [Related]
9. Pyrimidinergic receptor P2Y6 expression is elevated in lung adenocarcinoma and is associated with poor prognosis.
Wang X; Zhao B; Ren D; Hu X; Qiao J; Zhang D; Zhang Y; Pan Y; Fan Y; Liu L; Wang X; Ma H; Jia X; Song S; Zhao C; Liu J; Wang L
Cancer Biomark; 2023; 38(2):191-201. PubMed ID: 37545227
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of LncRNA-UCA1 Correlates with Lung Adenocarcinoma Progression and Poor Prognosis.
Chen L; Cao P; Wu Q; Guo Y; Yang Y; Chen F
Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868851
[TBL] [Abstract][Full Text] [Related]
11. High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma.
Jin CY; Du L; Nuerlan AH; Wang XL; Yang YW; Guo R
Aging (Albany NY); 2020 Dec; 13(3):3518-3535. PubMed ID: 33411689
[TBL] [Abstract][Full Text] [Related]
12. Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma.
Zhang J; Sun G; Mei X
Cancer Biomark; 2019; 26(3):367-373. PubMed ID: 31594212
[TBL] [Abstract][Full Text] [Related]
13.
Song X; Liu B; Zhao G; Pu X; Liu B; Ding M; Xue Y
Front Microbiol; 2022; 13():1046226. PubMed ID: 36601406
[TBL] [Abstract][Full Text] [Related]
14. Validating
Li X; Zuo H; Zhang L; Sun Q; Xin Y; Zhang L
Front Oncol; 2021; 11():720302. PubMed ID: 34527588
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of LRRC59 Is Associated with Poor Prognosis and Promotes Cell Proliferation and Invasion in Lung Adenocarcinoma.
Li D; Xing Y; Tian T; Guo Y; Qian J
Onco Targets Ther; 2020; 13():6453-6463. PubMed ID: 32753886
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
Wang W; Ren S; Wang Z; Zhang C; Huang J
Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma.
Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ
Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818
[No Abstract] [Full Text] [Related]
18. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma.
Wu YJ; Nai AT; He GC; Xiao F; Li ZM; Tang SY; Liu YP; Ai XH
World J Surg Oncol; 2021 Sep; 19(1):274. PubMed ID: 34517904
[TBL] [Abstract][Full Text] [Related]
19. CSF2RB Is a Unique Biomarker and Correlated With Immune Infiltrates in Lung Adenocarcinoma.
Zhu N; Yang Y; Wang H; Tang P; Zhang H; Sun H; Gong L; Yu Z
Front Oncol; 2022; 12():822849. PubMed ID: 35574409
[TBL] [Abstract][Full Text] [Related]
20. Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma.
Bian T; Zheng M; Jiang D; Liu J; Sun H; Li X; Liu L; Zhang J; Liu Y
Cancer Cell Int; 2021 Mar; 21(1):144. PubMed ID: 33653340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
